US Patent Issued to Betavive on Oct. 21 for "Peptides and fragments for treating diabetes and associated metabolic diseases" (Israeli Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,198, issued on Oct. 21, was assigned to Betavive Ltd. (Tirat Carmel, Israel).

"Peptides and fragments for treating diabetes and associated metabolic diseases" was invented by Yoram Palti (Haifa, Israel) and Dotan Zuri (Shekhanya, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides for peptides, fragments, compounds, compositions, and methods of use thereof for treating diabetes (e.g., type 1 diabetes, type 2 diabetes). In some aspects, methods comprise administering peptides, fragments, or a variant thereof to the subject for treating diabetes and diseases related to diabetes. In other aspects, compounds, compositions, and ...